Related Experiment Video
Updated: Aug 8, 2026
Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells
Published on: October 22, 2012
Mimotopes of tumor-associated T-cell epitopes for cancer vaccines determined with combinatorial peptide libraries
Tumenjargal Sherev1, Karl-Heinz Wiesmüller, Peter Walden
1Department of Dermatology and Allergy, Medical Faculty Charité, Humboldt University, Schumannstrasse 20/21, 10117, Berlin, Germany.
Abstract:
Cytotoxic T-cells are the most important effector cells in immune responses against tumors. The identification of tumor-associated epitopes for these cells, therefore, has become a key aspect of the development of cancer vaccines. Here, we describe a new approach to the determination of tumor-associated T-cell epitopes which employs combinatorial peptide libraries with singly defined sequence positions in a randomized context. The analysis of the responses of a T-cell clone to these libraries yields the amino acid constituents of the epitope which can be combined to obtain mimotopes that are suitable as vaccine antigens for the induction of tumor-specific responses.
Insights
Researchers developed a new method to find tumor-associated T-cell epitopes crucial for cancer vaccines. This approach uses peptide libraries to identify key amino acids for effective tumor-specific immune responses.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Cytotoxic T-cells are vital for anti-tumor immunity.
- Identifying tumor-associated T-cell epitopes is critical for cancer vaccine development.
Purpose of the Study:
- To introduce a novel method for determining tumor-associated T-cell epitopes.
- To enable the development of effective cancer vaccines.
Main Methods:
- Utilizing combinatorial peptide libraries with single defined sequence positions in a randomized context.
- Analyzing T-cell clone responses to these libraries.
Main Results:
- The method successfully identifies the amino acid constituents of T-cell epitopes.
- These identified epitopes can be used to create mimotopes.
Conclusions:
- The described approach facilitates the discovery of vaccine antigens.
- This leads to the induction of tumor-specific immune responses for cancer therapy.
Related Concept Videos
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...